BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32484860)

  • 1. Clinical Performance of the Roche SARS-CoV-2 Serologic Assay.
    Tang MS; Hock KG; Logsdon NM; Hayes JE; Gronowski AM; Anderson NW; Farnsworth CW
    Clin Chem; 2020 Aug; 66(8):1107-1109. PubMed ID: 32484860
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies.
    Favresse J; Eucher C; Elsen M; Tré-Hardy M; Dogné JM; Douxfils J
    Clin Chem; 2020 Aug; 66(8):1104-1106. PubMed ID: 32484887
    [No Abstract]   [Full Text] [Related]  

  • 3. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
    Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
    J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Performance of Two SARS-CoV-2 Serologic Assays.
    Tang MS; Hock KG; Logsdon NM; Hayes JE; Gronowski AM; Anderson NW; Farnsworth CW
    Clin Chem; 2020 Aug; 66(8):1055-1062. PubMed ID: 32402061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Serology: Much Hype, Little Data.
    Farnsworth CW; Anderson NW
    Clin Chem; 2020 Jul; 66(7):875-877. PubMed ID: 32343775
    [No Abstract]   [Full Text] [Related]  

  • 8. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
    Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
    [No Abstract]   [Full Text] [Related]  

  • 9. Labs scramble to produce new coronavirus diagnostics.
    Cohen J; Kupferschmidt K
    Science; 2020 Feb; 367(6479):727. PubMed ID: 32054740
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.
    Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE
    J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140
    [No Abstract]   [Full Text] [Related]  

  • 11. Serological characteristics of COVID-19 patients.
    Zhou M; Zhong J; Bi L; Shang P; Xing Y; Wang B; He J; Xu Y; Luo T; Ma M; Li Q
    Infect Dis (Lond); 2020 Oct; 52(10):749-750. PubMed ID: 32603629
    [No Abstract]   [Full Text] [Related]  

  • 12. Interpreting Diagnostic Tests for SARS-CoV-2.
    Sethuraman N; Jeremiah SS; Ryo A
    JAMA; 2020 Jun; 323(22):2249-2251. PubMed ID: 32374370
    [No Abstract]   [Full Text] [Related]  

  • 13. Serologic testing of coronaviruses from MERS-CoV to SARS-CoV-2: Learning from the past and anticipating the future.
    Al-Tawfiq JA; Memish ZA
    Travel Med Infect Dis; 2020; 37():101785. PubMed ID: 32534208
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid roll out of SARS-CoV-2 antibody testing: even at high levels of specificity, an important proportion of test results will be false positives.
    Gruer L; Bhopal R
    BMJ; 2020 Jul; 370():m2910. PubMed ID: 32699002
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein.
    Abravanel F; Miédouge M; Chapuy-Regaud S; Mansuy JM; Izopet J
    J Clin Virol; 2020 Sep; 130():104528. PubMed ID: 32771904
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary evaluation of Roche Cobas Elecsys Anti-SARS-CoV-2 chemiluminescence immunoassay.
    Lippi G; Salvagno GL; Pegoraro M; Militello V; Caloi C; Peretti A; De Nitto S; Bovo C; Lo Cascio G
    Clin Chem Lab Med; 2020 Oct; 58(11):e251-e253. PubMed ID: 32692698
    [No Abstract]   [Full Text] [Related]  

  • 18. Five-minute point-of-care testing for SARS-CoV-2: Not there yet.
    Hogan CA; Sahoo MK; Huang C; Garamani N; Stevens B; Zehnder J; Pinsky BA
    J Clin Virol; 2020 Jul; 128():104410. PubMed ID: 32403009
    [No Abstract]   [Full Text] [Related]  

  • 19. Beware of False-Positive Results with SARS-CoV-2 Antibody Tests.
    Ebell MH; Barry HC
    Am Fam Physician; 2020 Jul; 102(1):5-6. PubMed ID: 32603079
    [No Abstract]   [Full Text] [Related]  

  • 20. Limits of Detection of 6 Approved RT-PCR Kits for the Novel SARS-Coronavirus-2 (SARS-CoV-2).
    Wang X; Yao H; Xu X; Zhang P; Zhang M; Shao J; Xiao Y; Wang H
    Clin Chem; 2020 Jul; 66(7):977-979. PubMed ID: 32282874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.